Global Emergency Topical Hemostatic Agents Market Size, Share, and Trends Analysis Report, By Product Type (Thrombin Based Hemostats, Surgical Sealants, Combination Products), By End-User (Hospital, Ambulatory Surgical Centers, and Clinics), Forecast Period (2022-2028)

The global emergency topical hemostatic agents market is anticipated to grow at a 6.1% CAGR during the forecast period (2022-2028). The key driver of the emergency topical hemostasis agents market is the rise in global trauma and accident cases. Every year, an estimated 1.25 million people are killed in road traffic accidents around the globe, according to the World Health Organization. Hemorrhage or excessive bleeding is the cause of more than a third of pre-hospital global deaths, and more than 40% of deaths within the first 24 hours. Furthermore, according to research published by the US Armed Forces, 25% of battlefield fatalities are medically preventable. Uncontrolled blood loss is responsible for over 90% of these deaths. Due to a large number of deaths, governments have been urged to design and implement improved bleeding control methods.

According to the Centers for Disease Control and Prevention (CDC), hemophilia affects 1 in every 5,000 male births in the US. Another bleeding ailment, Von Willebrand disease (VWD), is the most common blood disorder in the US, affecting 1% of the population. Von Willebrand disease affects one out of every 100 people in the US (almost 3.2 million) (VWD). The use of hemostasis products rose as the number of patients with bleeding problems increased. Around the globe, the number of people suffering from such chronic diseases is rapidly increasing. As a result, the number of surgical treatments is projected to rise, propelling the emergency hemostasis market growth in the near future.

Some major players in the market include Omni-stat Medical Inc, CryoLife, Inc., Medical Device Business Services, Inc., Medtronic Plc., and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Company Products Offering

• Omni-stat Medical Inc offers OMNI-STAT 3(g) Hemostatic Granules, It is intended for external topical usage on a transitory basis. For minor to severe bleeding management, such as hairy areas, skin tears, lacerations, avulsions, punctures, or locations that are difficult or impossible to pack with normal gauze. For suture oozing and other types of topical external bleeding in the operating room.
• PerClot is an absorbable hemostatic device that is given to the sterile field in a double-barrier, sterile pouch. It is used to control bleeding during surgical procedures or after traumatic injuries.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product Type
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Omni-stat Medical Inc, CryoLife, Inc., Medical Device Business Services, Inc., Medtronic Plc., Pfizer Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Emergency Topical Hemostatic Agents Market Report by Segment

By Product Type

• Thrombin Based Hemostats
• Surgical Sealants
• Combination Products

By End-User

• Hospital
• Ambulatory Surgical Centers
• Clinics

Global Emergency Topical Hemostatic Agents Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa